Narelle S. Cox, Jennifer Follett, Karen O. McKay 

Slides:



Advertisements
Similar presentations
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Advertisements

Treatment compliance in children and adults with Cystic Fibrosis
Dorene F. Balmer, Joan I. Schall, Virginia A. Stallings 
Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis  Stefanie Hennig, Karen McKay, Suzanna Vidmar, Katie O'Brien,
Use of high-dose ibuprofen in a pediatric cystic fibrosis center
Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis  H.J.
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
John Widger, Sarath Ranganathan, Philip J. Robinson 
The ease of breathing test tracks clinical changes in cystic fibrosis
Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation  Shahid I. Sheikh, Frederick R. Long, Karen.
Controlled clinical trials in cystic fibrosis — are we doing better?
Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state  Bradley.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial  S.K. Kabra, R. Pawaiya, Rakesh Lodha,
Vitamin A and lung function in CF
Ghrelin and leptin levels in young adults with cystic fibrosis: Relationship with body fat  Charilaos Stylianou, Assimina Galli-Tsinopoulou, George Koliakos,
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure  I.J. Clifton, A.M. Morton, N.S. Ambrose,
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Elisabeth P. Dellon, Elaine Chen, Jessica Goggin, Karen Homa, Bruce C
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis  Joseph M. Collaco, Karen S. Raraigh, Lawrence.
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis  M.N. Hurley, A.H. Amin Ariff, C. Bertenshaw,
Lung clearance index during hospital admission in school-age children with cystic fibrosis  Liam Welsh, Christopher Nesci, Haily Tran, Marisol Tomai,
Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids  Francis J. Gilchrist, A.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
James H. Hull, Rachel Garrod, Timothy B. Ho, Ronald K. Knight, John R
Voriconazole therapy in children with cystic fibrosis
V. Terlizzi, A. Tosco, R. Tomaiuolo, A. Sepe, N. Amato, A. Casale, C
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
Treatment intensity and characteristics of MRSA infection in CF
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
Cystic fibrosis and pregnancy in the modern era: A case control study
Safety assessment of inhaled xylitol in subjects with cystic fibrosis
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Modified shuttle test performance in hospitalized children and adolescents with cystic fibrosis  Narelle S. Cox, Jennifer Follett, Karen O. McKay  Journal of Cystic Fibrosis  Volume 5, Issue 3, Pages 165-170 (August 2006) DOI: 10.1016/j.jcf.2006.02.004 Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Rate of perceived exertion scale. Journal of Cystic Fibrosis 2006 5, 165-170DOI: (10.1016/j.jcf.2006.02.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 The relationship between FEV1 and MST distance at admission and discharge. Journal of Cystic Fibrosis 2006 5, 165-170DOI: (10.1016/j.jcf.2006.02.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 The relationship between change in % predicted FEV1 and MST distance from admission to discharge. Journal of Cystic Fibrosis 2006 5, 165-170DOI: (10.1016/j.jcf.2006.02.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions